Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12397685rdf:typepubmed:Citationlld:pubmed
pubmed-article:12397685lifeskim:mentionsumls-concept:C0003018lld:lifeskim
pubmed-article:12397685lifeskim:mentionsumls-concept:C2709270lld:lifeskim
pubmed-article:12397685pubmed:issue10lld:pubmed
pubmed-article:12397685pubmed:dateCreated2002-10-25lld:pubmed
pubmed-article:12397685pubmed:abstractTextThe natriuretic peptide comprises at least three ligands(ANP, BNP, and CNP) and three receptors(GC-A, GC-B, and Clearance receptor). ANP and BNP are cardiac hormones, which regulate blood pressure and body fluid volume. Angiotensin II, the effector peptide of the renin-angiotensin system, regulates cellular growth in response to developmental, physiological and pathological processes. Recently, evidences suggest that cardiovascular homeostasis is determined by the balance between these two important counter-regulatory pathways. In this paper, we will discuss the molecular mechanism of the cross-talk between the two systems, including our recent findings using the mice deficient for GC-A and angiotensin II receptors. The results suggest that the endogenous natriuretic peptide system inhibits the cardiac angiotensin system and protects the heart from excessive pathological remodelings.lld:pubmed
pubmed-article:12397685pubmed:languagejpnlld:pubmed
pubmed-article:12397685pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12397685pubmed:citationSubsetIMlld:pubmed
pubmed-article:12397685pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12397685pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12397685pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12397685pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12397685pubmed:statusMEDLINElld:pubmed
pubmed-article:12397685pubmed:monthOctlld:pubmed
pubmed-article:12397685pubmed:issn0047-1852lld:pubmed
pubmed-article:12397685pubmed:authorpubmed-author:NakaoKazuwaKlld:pubmed
pubmed-article:12397685pubmed:authorpubmed-author:SaitoYoshihik...lld:pubmed
pubmed-article:12397685pubmed:authorpubmed-author:KishimotoIchi...lld:pubmed
pubmed-article:12397685pubmed:authorpubmed-author:LiYuhaoYlld:pubmed
pubmed-article:12397685pubmed:issnTypePrintlld:pubmed
pubmed-article:12397685pubmed:volume60lld:pubmed
pubmed-article:12397685pubmed:ownerNLMlld:pubmed
pubmed-article:12397685pubmed:authorsCompleteYlld:pubmed
pubmed-article:12397685pubmed:pagination1923-8lld:pubmed
pubmed-article:12397685pubmed:dateRevised2011-7-27lld:pubmed
pubmed-article:12397685pubmed:meshHeadingpubmed-meshheading:12397685...lld:pubmed
pubmed-article:12397685pubmed:meshHeadingpubmed-meshheading:12397685...lld:pubmed
pubmed-article:12397685pubmed:meshHeadingpubmed-meshheading:12397685...lld:pubmed
pubmed-article:12397685pubmed:meshHeadingpubmed-meshheading:12397685...lld:pubmed
pubmed-article:12397685pubmed:meshHeadingpubmed-meshheading:12397685...lld:pubmed
pubmed-article:12397685pubmed:meshHeadingpubmed-meshheading:12397685...lld:pubmed
pubmed-article:12397685pubmed:meshHeadingpubmed-meshheading:12397685...lld:pubmed
pubmed-article:12397685pubmed:meshHeadingpubmed-meshheading:12397685...lld:pubmed
pubmed-article:12397685pubmed:year2002lld:pubmed
pubmed-article:12397685pubmed:articleTitle[Cross-talk between the natriuretic peptide system and the angiotensin system].lld:pubmed
pubmed-article:12397685pubmed:affiliationKyoto University School of Medicine, Department of Medicine and Clinical Science.lld:pubmed
pubmed-article:12397685pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12397685pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:12397685pubmed:publicationTypeReviewlld:pubmed